Comparison of Vascular Function in Emergency Service Professionals (FIRECOP)

May 2, 2024 updated by: University of Edinburgh

Emergency Service Professionals have an increased risk of death from heart attacks when compared to the general public. All the emergency professions share similar responsibilities such as emergency call-outs and shift work. Heart disease is the commonest cause of on-duty death amongst fire-fighters accounting for 45% and compared with 22% in police officers and 15% in the general population. The unique risk to fire-fighters is likely to reflect a combination of factors including extreme physical exertion, mental stress, heat and pollutant exposure.

In this study the investigators will assess healthy career fire-fighters and age-matched healthy police officer control subjects following a sedentary period. The investigators will take blood samples to measure platelet activity (platelets are the particles in blood that help blood clot) and will examine how blood clots outside of the body. The investigators will then perform studies placing small needles in the arm to assess how the blood vessels respond following these duties. The investigators hypothesise that fire-fighters do not have pre-existing impairment of heart, blood or blood vessel function as a cumulative effect of their occupation, but rather these are acute and transitory effects following distinct fire-fighter duties. We therefore expect similar results in both occupational groups.

Study Overview

Study Type

Observational

Enrollment (Actual)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Edinburgh, United Kingdom, EH16 4SA
        • Royal Infirmary of Edinburgh Clinical Research Facility

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Subjects will be healthy, non-smoking, whole-time firefighters working within Lothian and Borders Fire and Rescue Service and age- and sex-matched police officers who are also healthy and non-smokers working within Lothian and Borders Police Force.

Description

Inclusion Criteria:

  • Non-smoking healthy firefighters

Exclusion Criteria:

  • Current smoker
  • History of lung or ischaemic heart disease
  • Malignant arrhythmia
  • Systolic blood pressure >190mmHg or <100mmHg
  • Renal or hepatic dysfunction
  • Previous history of blood dyscrasia
  • Unable to tolerate the supine position
  • Blood donation within the last 3 months
  • Recent respiratory tract infection within the past 4 weeks
  • Routine medication including aspirin and NSAIDs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Firefighters
20 firefighters will attend for vascular assessments following a minimum of 48 hours off-duty.
Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 µg/min).
Other Names:
  • BK
  • SNP
  • ACh
  • VP
Ex-vivo assessment of thrombus formation using the Badimon Chamber
Police Officers
20 police officers will attend for vascular assessments following a minimum of 48 hours off-duty.
Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 µg/min).
Other Names:
  • BK
  • SNP
  • ACh
  • VP
Ex-vivo assessment of thrombus formation using the Badimon Chamber

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Forearm blood flow measured by venous occlusion plethysmography in response to infused vasodilators
Time Frame: following 48 hours off duty
following 48 hours off duty

Secondary Outcome Measures

Outcome Measure
Time Frame
Ex-vivo thrombus formation using the Badimon chamber
Time Frame: following 48 hours off duty
following 48 hours off duty
Plasma t-PA and PAI concentrations following infusion of bradykinin
Time Frame: During forearm study, following 48 hours off duty
During forearm study, following 48 hours off duty

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: David E Newby, MD PhD, University of Edinburgh
  • Study Director: Nicholas L Mills, MBChB PhD, University of Edinburgh
  • Principal Investigator: Amanda L Hunter, MBChB, University of Edinburgh

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2012

Primary Completion (Actual)

April 1, 2013

Study Completion (Actual)

April 1, 2013

Study Registration Dates

First Submitted

March 14, 2013

First Submitted That Met QC Criteria

March 14, 2013

First Posted (Estimated)

March 18, 2013

Study Record Updates

Last Update Posted (Actual)

May 3, 2024

Last Update Submitted That Met QC Criteria

May 2, 2024

Last Verified

March 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 11-SS-0085
  • PG/11/27/28842 (Other Grant/Funding Number: British Heart Foundation)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vascular Function

Clinical Trials on Forearm Vascular Study

Subscribe